Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 6Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Advanced Solid Tumour 3Small Cell Lung Carcinoma 2Recurrence 2Multiple Myeloma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Advanced Breast Cancer 2Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuroma 1Neoplasms 1Neoplasm Metastasis 1Multiple Sclerosis 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Idiopathic Pulmonary Fibrosis 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Depression 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Blast Crisis 1

Interventions

Injections 3Paclitaxel 2Cisplatin 2Bevacizumab 2tislelizumab 1Pemetrexed 1Gemcitabine 1Fluorouracil 1Docetaxel 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Solid Tumour × Injections × 30 days × Clear all
NCT07111546 2026-05-26

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
140 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT06783647 2026-05-18

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
230 enrolled
Other solid neoplasm

Advanced Solid Tumour

NCT07331155 2026-05-18

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
110 enrolled
Other solid neoplasm

Advanced Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡